views

Filthy Forty Adamas – oh dear, the AIM farce continues

Back last August I covered the non-payment of monies due to AIM-listed Adamas (ADAM) following the redemption of a convertible bond Adamas held in a Chinese company, Global Pharm Holdings Group. It was owed millions - to have been settled by April 2015 - and numerous revised and re-revised deals were signed – not that the cash materialised. More to the point, Adamas seemed to be having a spot of bother tracking down the Chairman of that company. And so to yesterday’s update….